Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-11-30
1982-03-09
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
525 1, 525 3, 525 5, 525 6, 260465D, 560 29, 560 38, 564 44, 564 47, 564 48, 564 91, 564153, 564154, 564157, 424 78, 424309, 424321, 424322, 424324, C07C12160, C07C10322, A61K 31275, A61K 31165
Patent
active
043189210
ABSTRACT:
Novel 1-aryloxy-3-amidoamidoalkylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. Representative of the compounds disclosed is 1-(o-cyanophenoxy)-3-.beta.-(benzamidoacetamido)ethylaminopropan-2-ol.
REFERENCES:
patent: 3607859 (1971-09-01), Feder
patent: 3639476 (1972-02-01), Eberle et al.
patent: 3928412 (1975-12-01), Smith
patent: 3959369 (1976-05-01), Smith
patent: 4010189 (1977-03-01), Smith
patent: 4034106 (1977-07-01), Smith
patent: 4041075 (1977-08-01), Smith
patent: 4083992 (1978-04-01), Smith
patent: 4117157 (1978-09-01), Smith
patent: 4131685 (1978-12-01), Smith
patent: 4167581 (1979-09-01), Smith
patent: 4171374 (1979-10-01), Smith
Brust Joseph Paul
Imperial Chemical Industries Limited
LandOfFree
Alkanolamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkanolamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkanolamine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1840640